| |
|
|
|
Intec Pharma Ltd.  
|
|
4.39 0.19 (0.05%) |
06-21 16:00 |
|
Open: |
4.2 |
Pre close: |
4.2 |
Target:
|
5.96
|
|
High: |
4.51 |
Low: |
4.12 |
Resistance:
|
5.10
5.83
|
|
Volume: |
563,040 |
Market Cap: |
146M |
Support:
|
3.93
3.27
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.47
 |
MACD |
MACD(12,26):
|
-0.33 |
|
MA(20): |
4.90 |
Signal(12,26,9): |
-0.31 |
|
MA(100): |
6.59 |
Stochastic Oscillator |
%K(14,3):
|
24.35  |
|
MA(250): |
5.93 |
%D(3): |
21.13 |
|
Average Volume(K) |
3-Month: |
26117
|
52-Week |
High:
|
9.25 |
|
10-Days: |
42260 |
Low: |
3.55 |
|
RSI |
RSI(14):
|
34.05 |
Change(%): |
-1.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.318 |
Return on Equity (ttm) |
-93.6 |
Shares Out. (M) |
33.30 |
|
EPS Est. Current Year |
-1.670 |
Return on Assets (ttm) |
-48.8 |
Shares Float (M) |
23.76 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
16.08 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
40.23 |
|
Forward EPS |
-1.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
805 |
|
Book Value (p.s.) |
1.320 |
EBITDA (p.s.) |
-1.273 |
P/E |
-3.33 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.33 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-36.08 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-22.05 |
P/CF |
-4.05 |
|
|
|
|
|
|
